Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 30
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
Psychedelic Policy Push Continues: Over 60 Bills Introduced Across 22 States
January 2025 Psychedelic Paten Update: Lykos’ New Continuation Applications; Ambio Files...
Microdosing, Psychedelic Science, and the Future of Mental Health with Paul...
A Crucible of Academia, Psychedelics, and Religion: Psychedelic Intersections 2025 at...
UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in...
MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study
Opinions: PrEP’s Rollout Offers a Roadmap for Prescription Psychedelics
Exploring Psychedelist with Louis Dorian
Magic Mushrooms Meet Corporate Conspiracy: Steve Hely on Adult Swim’s Common...
Pα+ Psychedelic Bulletin #188: Q4’24 Lobbying Update; Virginia Lawmakers Question Purpose,...
Load more